ResMed (RMD)
(Delayed Data from NYSE)
$189.35 USD
+2.41 (1.29%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $189.26 -0.09 (-0.05%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth C Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 2.02 |
EPS Last Quarter | 2.13 |
Last EPS Surprise | 10.94% |
ABR | 1.96 |
Earnings ESP
|
-3.47% |
---|---|
Current Year | 7.70 |
Next Year | 8.72 |
EPS (TTM) | 7.25 |
P/E (F1) | 21.43 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.21B | 1.18B | 4.66B | 4.99B |
# of Estimates | 6 | 4 | 6 | 6 |
High Estimate | 1.23B | 1.19B | 4.69B | 5.09B |
Low Estimate | 1.19B | 1.18B | 4.62B | 4.90B |
Year ago Sales | 1.12B | 1.10B | 4.22B | 4.66B |
Year over Year Growth Est. | 7.49% | 7.18% | 10.46% | 7.03% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.02 | 2.03 | 7.70 | 8.72 |
# of Estimates | 4 | 3 | 5 | 5 |
Most Recent Consensus | 1.95 | 1.97 | 7.60 | 8.28 |
High Estimate | 2.11 | 2.09 | 7.77 | 9.29 |
Low Estimate | 1.95 | 1.97 | 7.60 | 8.28 |
Year ago EPS | 1.60 | 1.64 | 6.44 | 7.70 |
Year over Year Growth Est. | 26.09% | 23.58% | 19.63% | 13.21% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Current | 2.02 | 2.03 | 7.70 | 8.72 |
7 Days Ago | 2.02 | 2.02 | 7.70 | 8.72 |
30 Days Ago | 2.02 | 2.02 | 7.70 | 8.72 |
60 Days Ago | 2.00 | 2.02 | 7.64 | 8.67 |
90 Days Ago | 1.99 | 1.98 | 7.43 | 8.23 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.95 | 1.97 | 7.60 | 8.28 |
Zacks Consensus Estimate | 2.02 | 2.03 | 7.70 | 8.72 |
Earnings ESP | -3.47% | -2.96% | -1.30% | -5.05% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.13 | 1.88 | 1.64 | 1.60 | NA |
Estimate | 1.92 | 1.81 | 1.63 | 1.67 | NA |
Difference | 0.21 | 0.07 | 0.01 | -0.07 | 0.06 |
Surprise | 10.94% | 3.87% | 0.61% | -4.19% | 2.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more